Home LiteratureArticle Details
PMID: 2807549 Published · ppublish English Journal Article

Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi.

Infection and immunity ·Vol. 57 ·No. 12 ·1989-12-00 ·Pages 3823-7

Szu SC, Li XR, Schneerson R, Vickers JH, Bryla D, Robbins JB

Abstract

The effect of molecular weight or size of the components on the immunogenicity of polysaccharide-protein conjugates prepared with the native Vi capsular polysaccharide (Vi) (approximately 3 x 10(3) kilodaltons) or lower-molecular-weight Vi (Vis; approximately 46 kilodaltons) abound to cholera toxin (CT) or to its B subunit (CTB) was studied. In mice, Vi-CT, Vi-CTB, and Vis-CTB elicited higher Vi antibody levels than the Vi alone (P less than 0.0001). Vi-CT and Vi-CTB were more immunogenic than Vis-CTB (P less than 0.01). CT or Vi-CT elicited higher levels of CT antibodies, as measured by enzyme-linked immunosorbent assay, than did CTB or Vi-CTB. In rhesus monkeys, the Vi conjugates elicited higher Vi antibody levels than the Vi alone (P less than 0.01). Vi-CTB elicited higher levels of Vi antibody after each injection than did Vis-CTB. Similar levels of CT antibodies, as measured by enzyme-linked immunosorbent assay, were elicited by all three conjugates. In contrast, Vi-CT elicited higher levels of neutralizing antibodies than Vi-CTB or Vis-CTB when either CT or the related heat-labile toxin of Escherichia coli was used as the antigen. These results indicate that the holotoxin and the native Vi provide the most immunogenic components for conjugates designed to induce both Vi and CT antibodies.

MeSH Terms
Adjuvants, Immunologic Animals Antibodies, Bacterial/biosynthesis Antitoxins/biosynthesis Cholera Toxin/immunology Macaca mulatta Mice Molecular Weight Polysaccharides, Bacterial/immunology Salmonella typhi/immunology Typhoid-Paratyphoid Vaccines/immunology
Chemicals
Adjuvants, Immunologic Antibodies, Bacterial Antitoxins Polysaccharides, Bacterial Typhoid-Paratyphoid Vaccines Vi polysaccharide vaccine, typhoid Cholera Toxin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Szu S C
Laboratory of Developmental and Molecular Immunity, Food and Drug Administration, Bethesda, Maryland 20892.
Li X R
Schneerson R
Vickers J H
Bryla D
Robbins J B
References (36)
36 references, click to expand
  1. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
    J Infect Dis. 1986 Aug;154(2):342-5 PMID: 2425009
  2. Bacterial protein toxins with latent ADP-ribosyl transferases activities.
    Adv Enzymol Relat Areas Mol Biol. 1986;58:99-140 PMID: 3012972
  3. Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process.
    Carbohydr Res. 1986 Sep 1;152:7-20 PMID: 3768916
  4. Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.
    Infect Immun. 1986 Nov;54(2):448-55 PMID: 3095243
  5. Epitopes of the cholera family of enterotoxins.
    Rev Infect Dis. 1987 May-Jun;9(3):544-61 PMID: 2440089
  6. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    N Engl J Med. 1987 Oct 29;317(18):1101-4 PMID: 3657877
  7. Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.
    J Exp Med. 1987 Nov 1;166(5):1510-24 PMID: 3681191
  8. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
    Lancet. 1987 Nov 21;2(8569):1165-9 PMID: 2890805
  9. Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever.
    J Clin Microbiol. 1988 Apr;26(4):719-25 PMID: 3366868
  10. Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.
    Infect Immun. 1988 Sep;56(9):2292-8 PMID: 3410538
  11. Studies on Vi antigen. VI. Immunization of human beings with purified Vi antigen.
    Am J Hyg. 1954 Jul;60(1):52-62 PMID: 13180501
  12. Immunological response of the rabbit to Vi antigen.
    J Bacteriol. 1969 Jul;99(1):13-7 PMID: 5802598
  13. Immunological response of three mouse strains to typhoid vaccine and Vi antigen.
    J Bacteriol. 1969 Jul;99(1):8-12 PMID: 5802620
  14. The immunological responses observed in field studies in Africa with group A meningococcal vaccines.
    Prog Immunobiol Stand. 1971;5:485-91 PMID: 4633975
  15. Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin.
    J Biol Chem. 1973 Jun 10;248(11):3838-44 PMID: 4196584
  16. Detection of heat-labile Escherichia coli enterotoxin with the use of adrenal cells in tissue culture.
    Science. 1974 Jan 25;183(4122):334-6 PMID: 4587905
  17. Cross-reactivity between heat labile enterotoxins of Vibrio cholerae and Escherichia coli in neutralization tests in rabbit ileum and skin.
    Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Dec;81(6):757-62 PMID: 4592974
  18. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.
    Infect Immun. 1974 Feb;9(2):348-53 PMID: 4205947
  19. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Infect Immun. 1975 Dec;12(6):1290-4 PMID: 54336
  20. Neutralization of Salmonella toxin-induced elongation of Chinese hamster ovary cells by cholera antitoxin.
    Infect Immun. 1977 Mar;15(3):988-92 PMID: 67084
  21. Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid.
    Infect Immun. 1977 Nov;18(2):338-41 PMID: 336542
  22. Assay method for Vibrio cholerae and Escherichia coli enterotoxins by automated counting of floating chinese hamster ovary cells in culture medium.
    J Clin Microbiol. 1978 May;7(5):479-85 PMID: 350897
  23. Studies on Vi antigen. VII. Characteristics of the immune response in the mouse.
    Am J Hyg. 1957 Jan;65(1):81-93 PMID: 13402749
  24. The effect of variation in molecular weight on the antigenicity of dextran in man.
    Arch Biochem Biophys. 1958 Dec;78(2):306-18 PMID: 13618012
  25. Tissue sulfhydryl groups.
    Arch Biochem Biophys. 1959 May;82(1):70-7 PMID: 13650640
  26. Physicochemical and biological properties of sonically treated Vi antigen.
    J Bacteriol. 1967 Nov;94(5):1411-6 PMID: 4964477
  27. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.
    Biochem J. 1978 Sep 1;173(3):723-37 PMID: 708370
  28. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.
    Infect Immun. 1979 Jun;24(3):760-9 PMID: 89088
  29. Subunit number and arrangement in Escherichia coli heat-labile enterotoxin.
    Infect Immun. 1981 Sep;33(3):677-82 PMID: 7026442
  30. Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits.
    Infect Immun. 1982 Oct;38(1):267-72 PMID: 6183210
  31. Immunological differences among the cholera/coli family of enterotoxins.
    Diagn Microbiol Infect Dis. 1983 Jun;1(2):129-38 PMID: 6201315
  32. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    J Immunol. 1984 Jun;132(6):2736-41 PMID: 6233359
  33. Immunogenic properties of alpha (1----6) dextran, its protein conjugates, and conjugates of its breakdown products in mice.
    Scand J Immunol. 1984 Jun;19(6):541-50 PMID: 6204375
  34. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.
    Infect Immun. 1984 Sep;45(3):582-91 PMID: 6332076
  35. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    J Infect Dis. 1984 Sep;150(3):436-49 PMID: 6207249
  36. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.
    J Immunol. 1986 Aug 15;137(4):1181-6 PMID: 3016088
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1989-12-00
Pages
3823-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259911
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]